Co-Authors
This is a "connection" page, showing publications co-authored by MIEN-CHIE HUNG and NAOTO T UENO.
Connection Strength
1.010
-
Systemic gene therapy in human xenograft tumor models by liposomal delivery of the E1A gene. Cancer Res. 2002 Nov 15; 62(22):6712-6.
Score: 0.216
-
E1A is an oncogene and may immortalize normal cells, especially in combination with other oncoproteins. J Clin Oncol. 2001 Nov 01; 19(21):4183-4.
Score: 0.201
-
Growth suppression of low HER-2/neu-expressing breast cancer cell line MDA-MB-435 by tyrosine kinase inhibitor emodin. Oncol Rep. 1996 May; 3(3):509-11.
Score: 0.137
-
TIG1 promotes the development and progression of inflammatory breast cancer through activation of Axl kinase. Cancer Res. 2013 Nov 01; 73(21):6516-25.
Score: 0.114
-
Epidermal growth factor receptor tyrosine kinase inhibitor reverses mesenchymal to epithelial phenotype and inhibits metastasis in inflammatory breast cancer. Clin Cancer Res. 2009 Nov 01; 15(21):6639-48.
Score: 0.087
-
A novel hTERT promoter-driven E1A therapeutic for ovarian cancer. Mol Cancer Ther. 2009 Aug; 8(8):2375-82.
Score: 0.086
-
Bcl-2 antisense oligonucleotide overcomes resistance to E1A gene therapy in a low HER2-expressing ovarian cancer xenograft model. Cancer Res. 2005 Sep 15; 65(18):8406-13.
Score: 0.066
-
Osteoprogenitor-GMP crosstalk underpins solid tumor-induced systemic immunosuppression and persists after tumor removal. Cell Stem Cell. 2023 05 04; 30(5):648-664.e8.
Score: 0.056
-
EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer. J Exp Clin Cancer Res. 2014 Jul 23; 33:58.
Score: 0.030
-
P27(kip1) down-regulation is associated with trastuzumab resistance in breast cancer cells. Cancer Res. 2004 Jun 01; 64(11):3981-6.
Score: 0.015